Related news for:   cancer research

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.

18

Jul

New score to help navigate improved treatment for follicular lymphoma patients

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

04

Feb

New test predicts breast cancer patients at risk of relapse

Prof John Hooper & his team are working towards improving the diagnosis & treatment of ovarian cancer by developing a unique PET imaging agent that shows the exact location and extent of the tumour.

14

Aug

Increasing the visibility of cancer

The Equity Trustees’ Cancer Research Travel Grants have been awarded to Mater Research PhD student Johanna Erbani and Research Officer Dr Kavita Bisht.

31

May

Equity Trustees’ Cancer Research Travel Grants announced

Dr Cameron Turtle, a leading hematology oncologist and bone marrow transplant specialist at the Fred Hutchinson Cancer Research Center returned to Mater Research to share his latest research.

20

Mar

From Brisbane to Washington: former Mater researcher returns to share advances in cancer research